Overall rank by patents
#24,923
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 14 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C01B (NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; ; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C).
The verdict
According to USPTO PatentsView, OCP ranks #24,923 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 14 technology areas.
USPTO PatentsView assignee plate
Corpus R24923 · Foreign Corporation #24,923 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Nuflora International Pty Ltd (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
OCP · this assignee
44 score
3D Lighting Innovati… · lowest
7 score
What this shows OCP's Innovation Score is 44.5/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
OCP Sa is a focused PatentsView assignee: 14 CPC subclasses with 90.9% of grants classified under C01B (NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; ; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2017. By volume, OCP sits between Nuflora International Pty Ltd and Oeconnection Llc.
OCP Sa shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Nuflora International Pty Ltd
11 patents
Nuix Limited
11 patents
Nut Shell LLC
11 patents
OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NTLAB-SC”
11 patents
ODAWARA ENGINEERING CO., LTD.
11 patents
ODESSA SEPARATOR, INC.
11 patents
OECHSLER AG
11 patents
OECONNECTION LLC
11 patents
OCP SA
11 patents
What this shows OCP holds 11 patents at rank #24,908, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,908 in granted patent volume.
Other assignees with the most granted patents in OCP's primary technology class.
OCP's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 25% higher than 75% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 9.1% |
| 2018 | 1 | 9.1% |
| 2020 | 1 | 9.1% |
| 2021 | 2 | 18.2% |
| 2022 | 2 | 18.2% |
| 2023 | 1 | 9.1% |
| 2024 | 2 | 18.2% |
| 2025partial year | 1 | 9.1% |
Top 14 of 14 technology areas
Overall rank by patents
#24,923
of 50,000 tracked assignees
44.5 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.